HAFFNER Marlene E.
MARLENE E. HAFFNER, MD, MPH is the CEO of Haffner Associates, LLC a firm dedicated to the strategy, development and policy of drug development with a special emphasis on rare diseases and the products that treatment them.For 20 years, Dr. Haffner served as Director of the Office of Orphan Products Development (OOPD) of the Food […]HICKMAN James J.
James J. Hickman is the founder and current Chief Scientist of a biotechnology company, Hesperos, Inc., that is focusing on cell-based systems for drug discovery and toxicity. He is also the Founding Director of the NanoScience Technology Center and a Professor of Nanoscience Technology, Chemistry, Biomolecular Science, Material Science and Electrical Engineering at the University […]HO Calvin N.
Calvin N. Ho, PhD, is a Patient Reported Outcomes Scientist at AstraZeneca, where he ensures that patients’ experiences are captured and analyzed in clinical trials. Previously, as Science Project Coordinator at the Tuberous Sclerosis Alliance, Dr. Ho organized an Externally-Led Patient-Focused Drug Development (ELPFDD) meeting with the US Food and Drug Administration (FDA). He also […]LEE Brendan
Dr. Lee is the Robert and Janice McNair Endowed Chair, Professor, and Chairman of the Department of Molecular and Human Genetics, Director of the Center for Skeletal Medicine and Biology at Baylor College of Medicine, and co-Director of the Texas Medical Center Bone Disease Program of Texas. As a pediatrician and geneticist, Dr. Lee studies […]STANFORD William (Bill) L.
Dr. William (Bill) L. STANFORD, PhD, is trained as a chemist (Duke) and as an Immunologist (UNC at Chapel Hill). Currently, Dr. Stanford is a Senior Scientist at the Ottawa Hospital, a Full Professor at the University of Ottawa, Investigator in the Ottawa Institute of Systems Biology, Scientific Director of the Ottawa Human Pluripotent Stem […]